JS
Joan Stafslien
Director

Joan Stafslien insider trades: Ra Medical Systems (RMED) stock buys and sales

Director, Ra Medical Systems Last trade Nov 19, 2020 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2013
3
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joan reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 19, 2020RMED↑ Buy$25K
Oct 31, 2016NUVA↑ Buy$298K
Aug 15, 2014CFN↓ Sell$528K
May 19, 2014CFN↓ Sell$1.0M
Feb 19, 2014CFN↓ Sell$921K
Apr 2, 2013CFN↓ Sell$1.6M
Mar 28, 2013CFN↓ Sell$13K
Feb 15, 2013CFN↓ Sell$714K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Joan Stafslien's insider trades

Joan Stafslien is a director at Ra Medical Systems (RMED). Since Feb 15, 2013, Joan has reported 2 open-market purchases worth $323K and 6 sales worth $4.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (15 filings), grants and awards (14 filings), shares withheld for taxes (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.